Total net assets ($CAD):
$256.83 million

Asset allocation

Geographic allocation

Sector allocation

The top 15 holdings make up 82.52% of the Fund.
Top holdings Sector allocation (%)
Eli Lilly and Co Drugs 9.36%
UnitedHealth Group Inc Healthcare Services 7.81%
Johnson & Johnson Drugs 7.75%
Thermo Fisher Scientific Inc Healthcare Equipment 6.20%
AstraZeneca PLC Drugs 6.09%
Merck & Co Inc Drugs 6.06%
AbbVie Inc Drugs 5.47%
Stryker Corp Healthcare Equipment 5.01%
Danaher Corp Healthcare Equipment 4.88%
DexCom Inc Healthcare Equipment 4.53%
IQVIA Holdings Inc Drugs 4.50%
Abbott Laboratories Healthcare Equipment 4.06%
argenx SE Drugs 3.86%
Novartis AG Cl N Drugs 3.52%
SPDR S&P Biotech ETF (XBI) Exchange Traded Fund 3.42%